Beyond Air, Inc. XAIR

Company Overview

Beyond Air, Inc. is a U.S.-based medical device and biopharmaceutical company focused on the development and commercialization of nitric oxide (NO) delivery systems for respiratory and neurological applications. The company operates primarily in the healthcare and medical technology industries, with its core business centered on generating nitric oxide from ambient air rather than relying on traditional high-pressure gas cylinders. Its flagship commercial product is the LungFit platform, which is designed to deliver precise concentrations of nitric oxide for therapeutic use in hospital settings.

The company’s principal revenue drivers include sales and deployment of the LungFit PH system, associated consumables and service arrangements, and development-stage therapeutic programs leveraging nitric oxide technology. Beyond Air primarily serves hospitals, neonatal intensive care units, and healthcare providers treating pulmonary hypertension and related respiratory conditions. The company positions itself as an innovator through its cylinder-free nitric oxide generation technology, which seeks to reduce logistical complexity, storage risks, and operating costs associated with conventional nitric oxide delivery systems. Founded in 2011 and formerly known as AIT Therapeutics, the company evolved from a development-stage medical technology business into a commercial-stage healthcare company following U.S. regulatory clearances and public market financing activities.